GAD1 and schizophrenia: A recent study showed that even a small reduction (14%–16%) of the biosynthetic enzyme GAD67 in GABAergic boutons in prefrontal cortex is sufficient to differentiate the brains of schizophrenia patients from controls (e.g., Rocco, Lewis, & Fish, 2016).